Report Detail
Global Narcolepsy Therapeutics Market Insights, Forecast to 2025
- RnM2888606 |
- 16 February, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Narcolepsy Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Narcolepsy Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Narcolepsy Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Narcolepsy Therapeutics in these regions.
This research report categorizes the global Narcolepsy Therapeutics market by top players/brands, region, type and end user. This report also studies the global Narcolepsy Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Shire
Ligand Pharmaceuticals, Inc.
Market size by Product
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Market size by End User
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Narcolepsy Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Narcolepsy Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Narcolepsy Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Narcolepsy Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Narcolepsy Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Narcolepsy Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Narcolepsy Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Product
- 1.4.2 Central nervous system stimulants
- 1.4.3 Sodium Oxybate
- 1.4.4 Selective Serotonin Reuptake Inhibitor (SSRI)
- 1.4.5 Tricyclic Antidepressants
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Narcolepsy Therapeutics Market Size Growth Rate by End User
- 1.5.2 Narcolepsy With Cataplexy
- 1.5.3 Narcolepsy Without Cataplexy
- 1.5.4 Secondary Narcolepsy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Narcolepsy Therapeutics Market Size
- 2.1.1 Global Narcolepsy Therapeutics Revenue 2014-2025
- 2.1.2 Global Narcolepsy Therapeutics Sales 2014-2025
- 2.2 Narcolepsy Therapeutics Growth Rate by Regions
- 2.2.1 Global Narcolepsy Therapeutics Sales by Regions
- 2.2.2 Global Narcolepsy Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Narcolepsy Therapeutics Sales by Manufacturers
- 3.1.1 Narcolepsy Therapeutics Sales by Manufacturers
- 3.1.2 Narcolepsy Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Narcolepsy Therapeutics Revenue by Manufacturers
- 3.2.1 Narcolepsy Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Narcolepsy Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Narcolepsy Therapeutics Price by Manufacturers
- 3.4 Narcolepsy Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Narcolepsy Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Narcolepsy Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Narcolepsy Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Narcolepsy Therapeutics Sales by Product
- 4.2 Global Narcolepsy Therapeutics Revenue by Product
- 4.3 Narcolepsy Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Narcolepsy Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Narcolepsy Therapeutics by Countries
- 6.1.1 North America Narcolepsy Therapeutics Sales by Countries
- 6.1.2 North America Narcolepsy Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Narcolepsy Therapeutics by Product
- 6.3 North America Narcolepsy Therapeutics by End User
7 Europe
- 7.1 Europe Narcolepsy Therapeutics by Countries
- 7.1.1 Europe Narcolepsy Therapeutics Sales by Countries
- 7.1.2 Europe Narcolepsy Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Narcolepsy Therapeutics by Product
- 7.3 Europe Narcolepsy Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Narcolepsy Therapeutics by Countries
- 8.1.1 Asia Pacific Narcolepsy Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Narcolepsy Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Narcolepsy Therapeutics by Product
- 8.3 Asia Pacific Narcolepsy Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Narcolepsy Therapeutics by Countries
- 9.1.1 Central & South America Narcolepsy Therapeutics Sales by Countries
- 9.1.2 Central & South America Narcolepsy Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Narcolepsy Therapeutics by Product
- 9.3 Central & South America Narcolepsy Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Narcolepsy Therapeutics by Countries
- 10.1.1 Middle East and Africa Narcolepsy Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Narcolepsy Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Narcolepsy Therapeutics by Product
- 10.3 Middle East and Africa Narcolepsy Therapeutics by End User
11 Company Profiles
- 11.1 Addrenex Pharmaceuticals, Inc.
- 11.1.1 Addrenex Pharmaceuticals, Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Products Offered
- 11.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
- 11.2 Teva Pharmaceutical Industries Ltd.
- 11.2.1 Teva Pharmaceutical Industries Ltd. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Products Offered
- 11.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
- 11.3 Jazz Pharmaceuticals PLC
- 11.3.1 Jazz Pharmaceuticals PLC Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Products Offered
- 11.3.5 Jazz Pharmaceuticals PLC Recent Development
- 11.4 Graymark Healthcare, Inc.
- 11.4.1 Graymark Healthcare, Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Graymark Healthcare, Inc. Narcolepsy Therapeutics Products Offered
- 11.4.5 Graymark Healthcare, Inc. Recent Development
- 11.5 Arena Pharmaceuticals, Inc.
- 11.5.1 Arena Pharmaceuticals, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Products Offered
- 11.5.5 Arena Pharmaceuticals, Inc. Recent Development
- 11.6 BIOPROJET
- 11.6.1 BIOPROJET Company Details
- 11.6.2 Company Business Overview
- 11.6.3 BIOPROJET Narcolepsy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 BIOPROJET Narcolepsy Therapeutics Products Offered
- 11.6.5 BIOPROJET Recent Development
- 11.7 Shire
- 11.7.1 Shire Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Shire Narcolepsy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Shire Narcolepsy Therapeutics Products Offered
- 11.7.5 Shire Recent Development
- 11.8 Ligand Pharmaceuticals, Inc.
- 11.8.1 Ligand Pharmaceuticals, Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Products Offered
- 11.8.5 Ligand Pharmaceuticals, Inc. Recent Development
12 Future Forecast
- 12.1 Narcolepsy Therapeutics Market Forecast by Regions
- 12.1.1 Global Narcolepsy Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Narcolepsy Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Narcolepsy Therapeutics Market Forecast by Product
- 12.2.1 Global Narcolepsy Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Narcolepsy Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Narcolepsy Therapeutics Market Forecast by End User
- 12.4 North America Narcolepsy Therapeutics Forecast
- 12.5 Europe Narcolepsy Therapeutics Forecast
- 12.6 Asia Pacific Narcolepsy Therapeutics Forecast
- 12.7 Central & South America Narcolepsy Therapeutics Forecast
- 12.8 Middle East and Africa Narcolepsy Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Narcolepsy Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Narcolepsy Therapeutics . Industry analysis & Market Report on Narcolepsy Therapeutics is a syndicated market report, published as Global Narcolepsy Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Narcolepsy Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
